Thanks so much Richard Meiklejohn and Kyle Kruse 🚀 for featuring us on the #MedtechImpactPodcast!
Deep brain stimulation (DBS) is a neurosurgical procedure that treats neurological conditions by implanting electrodes into the brain to produce electrical impulses. These impulses can control abnormal brain activity and chemical imbalances that cause conditions like Parkinson's disease, essential tremor, and dystonia. Despite the benefits of DBS, less than 1% of the 25 million patients who are eligible to undergo the procedure opt-in due to the invasiveness of and risk associated with traditional open brain surgery. Nicolette Driscoll, CTO of NeuroBionics, joins this episode of the #MedtechImpactPodcast to share how their team is on a mission to change the status quo through bioelectronic medicine. NeuroBionics is developing devices that seamlessly integrate with the human body and aim to offer DBS with a minimally-invasive approach. As well as learning about this exciting technology, Nicky shares insights into the journey from academic researcher to entrepreneur, and how they decided to focus on a challenging commercialization journey that could positively impact patient lives. As one of the top startups in the UMassM2D2 accelerator program and recent winners of the 2024 Vision Award with MedTech Innovator, the NeuroBionics story is definitely one to follow, and is sure to leave you informed and inspired. Tune in to learn more - https://lnkd.in/eDAC8t_C #Medtech #Startups #KeepInnovating Kyle Kruse 🚀, Marc-Joseph Antonini, Polina Anikeeva, Tanner Skenderian, Evan Dakov, Hamsa Madhira, Erin Byrne Rousseau, PhD, Adam Cherepon, Riley Pieper, Alan Oslan, Jed Kennedy, Nancy Bullock, Tim Looney, Nan Doyle, Thomas Moore, PhD, Terry Murray, Thomas Ross, RV Krishnan, Bryan McLaughlin, Daniel Franke, Hijaz Haris, Maroun Farah, Bert Monna, Hamid Ramezanpour, Md Osman Goni Nayeem, Carolina Aguilar, Robert Murcko, Greg Cole.